Viewing Study NCT03941132


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2025-12-27 @ 12:31 PM
Study NCT ID: NCT03941132
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-24
First Post: 2019-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
Sponsor: University of British Columbia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module